Company / R&D per Share
KIORA PHARMACEUTICALS INC R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.29
FY2025
5-year range
$0.29 / $4.70
FY2021-FY2025
Trend
-93.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 8 years, ranging from $0.29 in FY2025 to $4.70 in FY2024.
Based on SEC 10-K filings.
0.29 in FY2025 with a 5-year CAGR of -26.0%.
Declined from $0.64 to $0.29 over the past 4 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -26.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 93.8% year-over-year.
- Peak r&d per share was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.29 | -93.8% |
| FY2024 | $4.70 | +632.9% |
| FY2021 | $0.64 | -51.4% |
| FY2020 | $1.32 | -50.1% |
| FY2019 | $2.65 | +342.9% |
| FY2018 | $0.60 | -28.0% |
| FY2017 | $0.83 | +134.3% |
| FY2016 | $0.35 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026